Cilostazol in the Management of Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|8|3|363-372

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.8, Iss.3, 2010-05, pp. : 363-372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of atherosclerosis with antiallergic medicine: a lesson from the mouse model

By Xiang Meixiang   Wang Jian’’an  

Future Cardiology, Vol. 3, Iss. 6, 2007-11 ,pp. : 595-599

Future Medicine

Access to resources Recommend Favorite

Vascular preventive measures: the progression from asymptomatic to symptomatic atherosclerosis management. Evidence on usefulness of early diagnosis in women and children

By Rubba Fabiana   Gentile Marco   Iannuzzi Arcangelo   Panico Salvatore   Mattiello Amalia   Quagliata Luigi   Triassi Maria   Rubba Paolo  

Future Cardiology, Vol. 6, Iss. 2, 2010-03 ,pp. : 211-220

Future Medicine

Access to resources Recommend Favorite

Cilostazol: A New Drug in the Treatment Intermittent Claudication

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 2, Iss. 3, 2007-11 ,pp. : 181-185

Bentham Science Publishers

Access to resources Recommend Favorite

Hemorrhagic Cholecystitis in an Elderly Patient Taking Aspirin and Cilostazol

By  

Case Reports in Gastroenterology, Vol. 2, Iss. 2, 2008-06 ,pp. : 203-207

Karger

Access to resources Recommend Favorite

New therapeutic effects of cilostazol in patients with ischemic disorders

By  

Current Vascular Pharmacology, Vol. 13, Iss. 3, 2015-05 ,pp. : 399-404

Bentham Science Publishers

Access to resources Recommend Favorite